Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision-Making

November 29, 2022—Viz.ai, which focuses on artificial intelligence (AI) algorithms and machine learning to increase the speed of diagnosis and care, announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will incorporate Cercare Perfusion, a fully automated, simple-to-use, patient-specific perfusion software, into the Viz.ai platform.

The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes.

Viz’s imaging features and functionality are being broadened to better serve institutions that perform MRI in the patient workflow. The infusion of Cercare Perfusion technology into the Viz.ai platform enhances the company’s flagship AI-powered neurovascular portfolio as well as the platform’s capabilities.

The company noted that quickly mapping brain perfusion deficits is pivotal to minimize tissue damage in acute stroke management. Cercare enriches the workflow with layers of AI to produce volumetric measures that directly impact clinical decision-making.

Cercare provides maps that illustrate oxygen availability, in addition to blood flow and volume. This allows more detailed assessment of tissue pathology and therefore optimized patient management for a variety of conditions, such as dementia and neoplasia.

Cercare Medical was founded by leading experts in perfusion imaging and AI in 2013 as a spin-out from Aarhus University in Aarhus, Denmark. Cercare Medical delivers the potential of perfusion imaging with a fully automated and multivendor-compatible software solution for CT and MRI perfusion imaging postprocessing.

Kim Beuschau Mouridsen, CEO of Cercare Medical, commented in the press release, “Viz.ai and Cercare Medical share the commitment to support clinical decision-making to enable the best possible patient care. We are pleased to enter this global partnership to increase access to the latest perfusion technology, which is designed to easily integrate into existing workflows to provide healthcare professionals with deep, fast, and reliable patient insights.”